LUNG CANCER (NON-SMALL CELL)
Clinical trials for LUNG CANCER (NON-SMALL CELL) explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER (NON-SMALL CELL) trials appear
Sign up with your email to follow new studies for LUNG CANCER (NON-SMALL CELL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to keep advanced lung cancer in check
Disease control CompletedThis study tested whether adding niraparib to the immunotherapy pembrolizumab helps keep advanced non-small cell lung cancer from growing after initial treatment. About 666 adults with stage IIIB/IV lung cancer whose disease had stabilized or shrunk after first-line chemo-immunot…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New combo shows promise against three tough cancers
Disease control CompletedThis study tested a new drug combination (IO102-IO103 plus pembrolizumab) as a first treatment for people with advanced lung, head/neck, or bladder cancer that had spread. A total of 63 patients took part. The goal was to see if the combo could shrink tumors and delay cancer grow…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE2 • Sponsor: IO Biotech • Aim: Disease control
Last updated May 14, 2026 12:03 UTC